This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.
Registration System for Prevention of Dementia to Begin Operation; Will Provide Info on Clinical Research, TrialsThe National Center of Neurology and Psychiatry (NCNP) announced on June 22 that it has set up a website to collect information from the general public on everyday cognitive function ...
- Panel to Discuss Zoster Vaccine’s Add’l Use, DPT Vaccine’s Booster Dose for Public Immunization Program (Jun.24)
- Teijin Pharma Will Block Feburic Generic Erosions by Expanding Indications: President (Jun.24)
- Cellular Dynamics, US National Eye Institute Ink Pact to Advance Cell Transplantation Therapy for AMD (Jun.24)
- Univ. of Tokyo, Astellas to Codevelop Rice-Based Oral Cholera Vaccine (Jun.24)
- Sanofi’s Antibody Drug for Atopic Dermatitis Close to Regulatory Filing (Jun.23)
|Bayer Japan Revs Up Drive to Spark Behavior Change, Offers Patient Insights to Back Office Staffers (Jun.22)||Jannie Oosthuizen to Lead MSD Japan from July (Jun.21)||PD-1’s “Actual Physiology Remains Unclear”: Discoverer of PD-1 (Jun.21)|
- Panel to Discuss Zoster Vaccine’s Add’l Use, DPT Vaccine’s Booster Dose for Public Immunization Program(Jun.24)
- Registration System for Prevention of Dementia to Begin Operation; Will Provide Info on Clinical Research, Trials(Jun.24)
- MHLW Official Vows to Swiftly Present Proposal on “Optimal Use of Innovative Drugs”: Chuikyo(Jun.23)
- NPO Asks MHLW to Take Steps to Ensure Proper Use of Xeplion(Jun.23)
- PMDA Chief Brings Together Drug Makers, Tech Vendors to Compile Proposal on Digital Health(Jun.17)
- Re-Pricing Rules Need Drastic Overhaul, Possible Abolishment Should Be Discussed for Z2: FPMAJ(Jun.14)